| Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) A Agarwal, A Mukherjee, G Kumar, P Chatterjee, T Bhatnagar, P Malhotra bmj 371, 2020 | 828 | 2020 |
| Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach S Mandal, T Bhatnagar, N Arinaminpathy, A Agarwal, A Chowdhury, ... Indian Journal of Medical Research 151 (2-3), 190-199, 2020 | 358 | 2020 |
| Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 MV Murhekar, T Bhatnagar, S Selvaraju, K Rade, V Saravanakumar, ... Indian Journal of Medical Research 152 (1-2), 48-60, 2020 | 215 | 2020 |
| SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey MV Murhekar, T Bhatnagar, S Selvaraju, V Saravanakumar, ... The Lancet Global Health 9 (3), e257-e266, 2021 | 196 | 2021 |
| Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use T Bhatnagar, MV Murhekar, M Soneja, N Gupta, S Giri, N Wig, ... Indian Journal of Medical Research 151 (2-3), 184-189, 2020 | 149 | 2020 |
| SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021 MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ... International Journal of Infectious Diseases 108, 145-155, 2021 | 135 | 2021 |
| Optimal governance and implementation of vaccination programmes to contain the COVID-19 pandemic M Piraveenan, S Sawleshwarkar, M Walsh, I Zablotska, S Bhattacharyya, ... Royal Society open science 8 (6), 210429, 2021 | 96 | 2021 |
| Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020 N Gupta, I Praharaj, T Bhatnagar, JWV Thangaraj, S Giri, H Chauhan, ... Indian Journal of Medical Research 151 (2-3), 236-240, 2020 | 96 | 2020 |
| Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22-April 30, 2020 P Abraham, N Aggarwal, GR Babu, S Barani, B Bhargava, T Bhatnagar, ... Indian Journal of Medical Research 151 (5), 424-437, 2020 | 78 | 2020 |
| Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ... PLoS medicine 18 (12), e1003877, 2021 | 68 | 2021 |
| National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance MS Kumar, T Bhatnagar, P Manickam, VS Kumar, K Rade, N Shah, S Kant, ... Indian Journal of Medical Research 151 (5), 419-423, 2020 | 60 | 2020 |
| Prevalence of open defecation among households with toilets and associated factors in rural south India: an analytical cross-sectional study N Yogananth, T Bhatnagar Transactions of the Royal Society of Tropical Medicine and Hygiene 112 (7 …, 2018 | 58 | 2018 |
| Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals A Rajamanickam, NP Kumar, AN Pandiarajan, N Selvaraj, S Munisankar, ... Scientific reports 11 (1), 20254, 2021 | 56 | 2021 |
| Malnutrition in a population of HIV-positive and HIV-negative drug users living in Chennai, South India AM Tang, T Bhatnagar, R Ramachandran, K Dong, S Skinner, MS Kumar, ... Drug and alcohol dependence 118 (1), 73-77, 2011 | 52 | 2011 |
| Private practitioners’ knowledge, attitude and practices about tuberculosis, Hooghly district, India K Datta, T Bhatnagar, M Murhekar Indian J Tuberc 57 (4), 199-206, 2010 | 50 | 2010 |
| Drug prescription practices: a household study in rural Varanasi T Bhatnagar, CP Mishra, RN Mishra Indian J Prev Soc Med 34 (1), 33-9, 2003 | 44 | 2003 |
| Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B. 1.617. 2/Delta variant in India, 2021: a multi-centric hospital-based case … T Bhatnagar, S Chaudhuri, M Ponnaiah, PD Yadav, R Sabarinathan, ... International Journal of Infectious Diseases 122, 693-702, 2022 | 39 | 2022 |
| Risk reduction and perceived collective efficacy and community support among female sex workers in Tamil Nadu and Maharashtra, India: the importance of context M Guha, A Baschieri, S Bharat, T Bhatnagar, SS Sane, SV Godbole, ... J Epidemiol Community Health 66 (Suppl 2), ii55-ii61, 2012 | 33 | 2012 |
| PLACID Trial Collaborators: Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID … A Agarwal, A Mukherjee, G Kumar, P Chatterjee, T Bhatnagar, P Malhotra Bmj 371, m3939, 2020 | 32 | 2020 |
| Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis N Jahan, A Brahma, MS Kumar, BS Bagepally, M Ponnaiah, T Bhatnagar, ... International Journal of Infectious Diseases 116, 59-67, 2022 | 31 | 2022 |
